Lista de obras - Georgia Beasley - Dominio Público Uruguay

A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion

scientific article published on 06 June 2012

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

artículo científico publicado en 2009

A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities

artículo científico publicado en 2011

A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion

artículo científico publicado en 2014

A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma

artículo científico publicado en 2012

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.

artículo científico publicado en 2009

A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.

artículo científico publicado en 2012

A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma

Age and gender differences in substance screening may underestimate injury severity: a study of 9793 patients at level 1 trauma center from 2006 to 2010.

artículo científico publicado en 2013

Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma

artículo científico publicado en 2012

Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma

artículo científico publicado en 2014

Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?

artículo científico publicado en 2017

Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma

artículo científico publicado en 2015

Contemporary Approaches to In-Transit Melanoma

Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models

artículo científico publicado en 2008

Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution

artículo científico publicado en 2011

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

artículo científico publicado en 2020

Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?

artículo científico publicado en 2018

Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.

artículo científico publicado en 2013

Future directions in regional treatment strategies for melanoma and sarcoma.

scientific article published on May 2008

HEPATIC ABSCESS

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma

artículo científico publicado en 2013

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma

artículo científico publicado en 2014

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

artículo científico publicado en 2014

Ipilimumab and Radiation in Patients with High Risk Resected or Regionally Advanced Melanoma

artículo científico publicado en 2020

Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion

artículo científico publicado en 2008

Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms

artículo científico publicado en 2011

Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics

artículo científico publicado en 2017

Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion

artículo científico publicado en 2011

Optimizing Regional Therapy for Melanoma

artículo científico publicado en 2009

Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?

scientific article published on 30 January 2009

Optimizing regional infusion treatment strategies for melanoma of the extremities

artículo científico publicado en 2009

Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma

artículo científico publicado en 2012

Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion

artículo científico publicado en 2013

Predicting disease progression after regional therapy for in-transit melanoma

artículo científico publicado en 2013

Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.

artículo científico publicado en 2009

Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers

scientific article published on 01 June 2015

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

artículo científico publicado en 2011

Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma

artículo científico publicado en 2013

SRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma

artículo científico publicado en 2013

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study

artículo científico publicado en 2017

Simultaneous Diaphragm and Liver Resection: A Propensity-Matched Analysis of Postoperative Morbidity

artículo científico publicado en 2012

Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy

artículo científico publicado en 2010

Standardizing Regional Therapy: Developing a Consensus on Optimal Utilization of Regional Chemotherapy Treatments in Melanoma

scientific article published on 01 July 2011

Surveillance strategies in the follow-up of melanoma patients: too much or not enough?

artículo científico publicado en 2017

Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma

artículo científico publicado en 2015

The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients

artículo científico publicado en 2018

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

scientific article published in 2022

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

artículo científico publicado en 2013

Updates in adjuvant systemic therapy for melanoma.

artículo científico publicado en 2018

What's new in neoadjuvant therapy for breast cancer?

scientific article published on January 2010

Lista de obras de Georgia Beasley

A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities

A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion

A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.

A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.

A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma

Age and gender differences in substance screening may underestimate injury severity: a study of 9793 patients at level 1 trauma center from 2006 to 2010.

Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma

Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma

Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?

Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma

Contemporary Approaches to In-Transit Melanoma

Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models

Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?

Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.

Future directions in regional treatment strategies for melanoma and sarcoma.

HEPATIC ABSCESS

Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma

Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

Ipilimumab and Radiation in Patients with High Risk Resected or Regionally Advanced Melanoma

Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion

Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms

Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics

Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion

Optimizing Regional Therapy for Melanoma

Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?

Optimizing regional infusion treatment strategies for melanoma of the extremities

Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma

Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion

Predicting disease progression after regional therapy for in-transit melanoma

Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.

Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma

Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma

SRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma

Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study

Simultaneous Diaphragm and Liver Resection: A Propensity-Matched Analysis of Postoperative Morbidity

Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy

Standardizing Regional Therapy: Developing a Consensus on Optimal Utilization of Regional Chemotherapy Treatments in Melanoma

Surveillance strategies in the follow-up of melanoma patients: too much or not enough?

Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma

The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy

Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.

Updates in adjuvant systemic therapy for melanoma.

What's new in neoadjuvant therapy for breast cancer?